m6A modification: recent advances, anticancer targeted drug discovery and beyond

被引:0
作者
Li-Juan Deng
Wei-Qing Deng
Shu-Ran Fan
Min-Feng Chen
Ming Qi
Wen-Yu Lyu
Qi Qi
Amit K. Tiwari
Jia-Xu Chen
Dong-Mei Zhang
Zhe-Sheng Chen
机构
[1] Jinan University,Formula
[2] Jinan University,pattern Research Center, School of Traditional Chinese Medicine
[3] Jinan University,Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy
[4] The University of Toledo,Clinical Translational Center for Targeted Drug, Department of Pharmacology, School of Medicine
[5] St. John’s University,Department of Pharmacology and Experimental Therapeutics
来源
Molecular Cancer | / 21卷
关键词
m6A; Cancer; Modulators; Drug discovery; Natural product; Chemosynthesis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 1203 条
[1]  
Wiener D(2021)The epitranscriptome beyond m(6)a Nat Rev Genet 22 119-131
[2]  
Schwartz S(2020)The potential role of RNA N6-methyladenosine in cancer progression Mol Cancer 19 88-63
[3]  
Wang T(2021)The role of m6A modification in the biological functions and diseases Signal Transduct Target Ther 6 74-7255
[4]  
Kong S(2021)Regulatory role and mechanism of m(6)a RNA modification in human metabolic diseases Mol Ther Oncolytics 22 52-894
[5]  
Tao M(2021)A comprehensive review of m6A/m6Am RNA methyltransferase structures Nucleic Acids Res 49 7239-601
[6]  
Ju S(2020)M(6)A-binding proteins: the emerging crucial performers in epigenetics J Hematol Oncol 13 35-482
[7]  
Jiang X(2020)Recent developments of small molecules targeting RNA m(6)a modulators Eur J Med Chem 196 112325-27
[8]  
Liu B(2019)Chemical inhibitors make their RNA epigenetic mark Nat Rev Drug Discov 18 892-703
[9]  
Nie Z(2021)Small molecule inhibition of METTL3 as a strategy against myeloid leukaemia Nature. 593 597-930
[10]  
Duan L(2020)Identification of anti-cancer compounds from natural products Chin J Nat Med 18 481-269